ID   JHOS-3
AC   CVCL_4648
SY   JHOS3
DR   CLO; CLO_0051450
DR   ArrayExpress; E-MTAB-3610
DR   BioSample; SAMN03472097
DR   CCLE; JHOS3_OVARY
DR   Cell_Model_Passport; SIDM00304
DR   Cosmic-CLP; 1480358
DR   DepMap; ACH-002146
DR   GDSC; 1480358
DR   GEO; GSM1669956
DR   PharmacoDB; JHOS3_690_2019
DR   RCB; RCB1546
DR   Wikidata; Q54898658
RX   PubMed=27397505;
RX   PubMed=30485824;
RX   PubMed=30894373;
CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC   Part of: COSMIC cell lines project.
CC   Microsatellite instability: Stable (MSS) (Sanger).
CC   Omics: Deep exome analysis.
CC   Omics: DNA methylation analysis.
CC   Omics: Genome sequenced.
CC   Omics: Transcriptome analysis.
CC   Genome ancestry: African=0%; Native American=0%; East Asian, North=83.55%; East Asian, South=16.2%; South Asian=0.24%; European, North=0%; European, South=0% (PubMed=30894373).
ST   Source(s): Cosmic-CLP; PubMed=30485824; RCB
ST   Amelogenin: X
ST   CSF1PO: 12,13
ST   D13S317: 10
ST   D16S539: 9,12
ST   D21S11: 29
ST   D5S818: 13
ST   D7S820: 10
ST   TH01: 6
ST   TPOX: 9,11 (Cosmic-CLP; RCB)
ST   TPOX: 11 (PubMed=30485824)
ST   vWA: 18
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens
SX   Female
AG   48Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 06-09-19; Version: 17
//
RX   PubMed=27397505; DOI=10.1016/j.cell.2016.06.017;
RA   Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P.,
RA   Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H.,
RA   Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H.,
RA   Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X.,
RA   Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M.,
RA   Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M.,
RA   Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A.,
RA   Saez-Rodriguez J., McDermott U., Garnett M.J.;
RT   "A landscape of pharmacogenomic interactions in cancer.";
RL   Cell 166:740-754(2016).
//
RX   PubMed=30485824; DOI=10.1016/j.celrep.2018.10.096;
RA   Papp E., Hallberg D., Konecny G.E., Bruhm D.C., Adleff V., Noe M.,
RA   Kagiampakis I., Palsgrove D., Conklin D., Kinose Y., White J.R.,
RA   Press M.F., Drapkin R., Easwaran H., Baylin S.B., Slamon D.,
RA   Velculescu V.E., Scharpf R.B.;
RT   "Integrated genomic, epigenomic, and expression analyses of ovarian
RT   cancer cell lines.";
RL   Cell Rep. 25:2617-2633(2018).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z., Monteiro A.N., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//